Phase II Study of Maximal Ablative Irradiation Because of Encasement (MAIBE) for Patients With Potentially Resectable Locally Advanced Pancreatic Cancer
The purpose of this phase II study is to test whether receiving a dose of radiation that is higher than the standard dose, in combination with chemotherapy, improves the chance of becoming a candidate for surgery and improves the chance of extending the patient's life.
Study ID: 18-090
Trial Phase: Phase II
Trial Sponsor: Memorial Sloan Kettering
Therapies Used in This Trial: Fluorouracil, Capecitabine, Leucovorin, Hypofractionated radiation therapy